Company | Name | Exchange | Sector | Industry | Beta (1y) | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
One Experience | Paris | Technology | Financial Technology (Fintech) & Infrastructure | 2.71 | EUR 3.66M | -2.5x | EUR 0.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | 2.54 | EUR 50.79M | -1.1x | 0.02 | EUR 0.72 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Teract | Paris | Consumer Cyclicals | Specialty Retailers | 2.04 | EUR 76.33M | -2.8x | EUR 1.04 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Forvia | Paris | Consumer Cyclicals | Automobiles & Auto Parts | 1.89 | EUR 1.69B | 8.5x | 0.02 | EUR 8.59 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | 1.8 | EUR 16.32M | -3.5x | 0.2 | EUR 4.36 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sartorius Stedim | Paris | Healthcare | Healthcare Equipment & Supplies | 1.56 | EUR 19.52B | 118.3x | -1.83 | EUR 200.60 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ |